Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000171734 | SCV000055249 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Ambry Genetics | RCV000248078 | SCV000319039 | likely benign | Cardiovascular phenotype | 2019-02-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001085477 | SCV000563320 | benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000853027 | SCV000995784 | benign | Primary dilated cardiomyopathy; Amyloidosis | 2018-10-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000171734 | SCV001915444 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253263 | SCV002524891 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001699217 | SCV004242116 | likely benign | not specified | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699217 | SCV001925578 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699217 | SCV001952663 | benign | not specified | no assertion criteria provided | clinical testing |